Opsonix raises $8M for device that filters pathogens from blood
Opsonix, a Cambridge spinout based on technology from Harvard University, just raised $8 million in a Series A for its device that filters a variety of pathogens from the bloodstream - preventing diseases like sepsis from becoming full-blown.